https://pittplusme.org/study/1950
ARQ-151-312 – Eczema Study
We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Do you have eczema? You may be able to participate in a study to find out if a new study drug (a cream) works and is safe to use on eczema. This study includes 4 in-person visits, and involves putting on the study cream (or placebo) every night for 28 nights and undergoing one blood draw. Compensation is provided.
IRB: SSU00137808B
- Arcutis Biotherapeutics, Inc. - ARQ-151-312, A Phase 3, 4-Week, Parallel Group, Double Blind, Vehicle-Controlled Study of the Safety and Efficacy of ARQ-151 Cream 0.15% Administered QD in Subjects with Atopic Dermatitis (Pro00047993)
AGE:
18 and up
DURATION:
Up to 8 weeks
VISITS:
4
LOCATION:
Falk Medical Building - Oakland
COMPENSATION:
$75 per visit & an additional $35 per photo visit
SHARE STUDY
MEET THE RESEARCHER
Laura Ferris
Laura Korb Ferris, MD, PhD, is Professor of Dermatology at the University of Pittsburgh School of Medicine, and is also the Director of Clinical Trials for the Department of Dermatology. Dr. Ferris earned her doctorate in immunology from Johns Hopkins University and her medical degree from the University of Maryland.